Research letter
Preoperative hypertension increases intraoperative bleeding in patients undergoing Mohs micrographic surgery

https://doi.org/10.1016/j.jaad.2018.08.005Get rights and content

First page preview

First page preview
Click to open first page preview

References (5)

  • J.L. Cook et al.

    A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery

    Arch Dermatol

    (2003)
  • M. Alam et al.

    Adverse events associated with Mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers

    JAMA Dermatol

    (2013)
There are more references available in the full text version of this article.

Cited by (9)

  • Preventing complications in dermatologic surgery: Presurgical concerns

    2021, Journal of the American Academy of Dermatology
    Citation Excerpt :

    Elderly patients may experience benign essential tremors, musculoskeletal issues, or cognitive decline that complicate perioperative and postoperative care.36 While intraoperative bleeding caused by hypertension can slightly increase operative times, a study of elderly patients undergoing MMS found that mild to moderate hypertension did not pose a significant risk and should not prevent or delay surgery.37 In cases of severe hypertension, cardiology guidelines recommend considering a delay for elective major surgery.38

  • Patient-Centered Care in Dermatologic Surgery: Practical Strategies to Improve the Patient Experience and Visit Satisfaction

    2019, Dermatologic Clinics
    Citation Excerpt :

    It is a common practice to assess a patient for pain in the inpatient setting, but there is not a universal pain assessment strategy for dermatologic surgery. Approximately one-third3 of Mohs patients report procedural pain, many of whom experience moderate or severe pain.22 Risk factors for pain include 3 or more intraoperative stages for tumor clearance or sensitive anatomic sites such as nose and periorbital skin.24

View all citing articles on Scopus

Funding sources: None.

Conflicts of interest: None disclosed.

View full text